Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2000
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066754A1 Protein c derivatives
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066635A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066612A1 Androgen glycosides and androgenic activity thereof
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000WO2000066599A1 Antioxidative vitamin b6 analogs
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066580A2 Antifungal ethers
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066553A1 Substituted indole sulfonamides as antiviral agents
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066524A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066173A2 Targeting of infectious agents bearing host cell proteins
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066144A2 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections
11/09/2000WO2000066141A2 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066126A2 Liposome compositions for improved drug retention
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066100A2 2r,4s-hydroxyitraconazole isomers
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000065915A1 Infection resistant polymers, their preparation and uses
11/09/2000WO2000042045A3 Functionalized heterocycles as chemokine receptor modulators
11/09/2000WO2000041463A3 Combination of hepatitis b vaccine with antiviral agents
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000039095A3 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000037105A3 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
11/09/2000WO2000035460A3 Pharmaceutical formulations
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000032226A3 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000014112A3 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000001349A3 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000DE19922444A1 Verfahren zur Behandlung von TNF-Rezeptor vermittelten Krankheiten A method for the treatment of TNF-receptor-mediated diseases
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000DE19920816A1 Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben Cephaibols new antiparasitic drugs from Acremonium tubakii, processes for their preparation and use thereof
11/09/2000DE19920790A1 Bis-Sulfonamide mit anti-HCMV-Wirkung Bis-sulfonamides with anti-HCMV activity
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372790A1 Monthly doses for treatment of streptococcus pneumonia infections
11/09/2000CA2372672A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000CA2372235A1 Conserved neisserial antigens
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2371621A1 Substituted indole sulfonamides as antiviral agents
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371483A1 Liposome compositions for improved drug retention
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2369550A1 Methods and formulations for targeting infectious agents bearing host cell proteins
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/09/2000CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000CA2365900A1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000CA2338799A1 Protein c derivatives
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050304A1 Liquid ophthalmic preparations
11/08/2000EP1050300A2 Selective antibacterial composition
11/08/2000EP1049796A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
11/08/2000EP1049788A2 Protein expression in baculovirus vector expression systems
1 ... 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 ... 1798